Sino Biopharmaceutical Ltd. Reg.Subdivided Shares HD -,025

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

7.17%

Market Cap

8.88 Bil.

P/E Ratio

43.77

Dividend Yield

1.62 %

Earnings per Share

0.02 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.496 G0 Units
PRICE DETERMINATION TIME06/19/2026 / 02:18:05 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.4960.4958
PREV. DAY'S PRICE0.4981 (06/18)
CHANGE DAY BEFORE
-0.00
-0.42 %
52 WEEK HIGH / LOW0.9924 (09/05)0.4804 (06/08)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE0.030.030.020.010.02
DIVIDENDS PER SHARE0.010.010.010.010.01
DIVIDEND YIELD IN %--1.62 %2.19 %1.44 %
DIVIDEND GROWTH IN %--37.11 %40.39 %-59.46 %
PRICE - EARNINGS RATIO16.7218.4343.7730.1624.95
PRICE - BOOK RATIO--3.241.691.90
PRICE - SALES RATIO--3.231.872.22
PRICE - CASH FLOW RATIO--9.036.468.80
Further Key Figures

Master Data

WKN
A0CBDJ
ISIN
KYG8167W1380
SYMBOL
SMZ1
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Sino Biopharmaceutical
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Hong Kong Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
17.84 Bil.
MARKET CAPITALISATION
8.88 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.05 %
-14.42 %
-24.76 %
-28.86 %
-7.17 %
12.18 %
-38.73 %
-25.88 %
HIGH0.520.570.690.800.990.990.990.80
LOW0.500.480.480.480.480.270.270.48
Dividend
per share

Company profile

Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.